Unithroid Tablet
NDC Package 60846-803-01
Package Information
Unithroid (levothyroxine sodium) tablets is hypothyroidismUNITHROID is indicated in pediatric and adult patients as a replacement therapy in primary (thyroidal), secondary (pituitary), and tertiary (hypothalamic) congenital or acquired hypothyroidism.Pituitary Thyrotropin (Thyroid-Stimulating Hormone, TSH) Suppression UNITHROID is indicated in pediatric and adult patients as an adjunct to surgery and radioiodine therapy in the management of thyrotropin-dependent well-differentiated thyroid cancer.Limitations of Use:UNITHROID is not indicated for suppression of benign thyroid nodules and nontoxic diffuse goiter in iodine-sufficient patients as there are no clinical benefits and overtreatment with UNITHROID may induce hyperthyroidism [see Warnings and Precautions (5.4)].UNITHROID is not indicated for treatment of hypothyroidism during the recovery phase of subacute thyroiditis. This formulation utilizes a tablet delivery system. Marketed by Amneal Pharmaceuticals Llc, this product is identified by NDC 60846-803 and is authorized under FDA application NDA021210.
Identification & Billing
- RxCUI: 892246 - levothyroxine sodium 100 MCG Oral Tablet
- RxCUI: 892246 - levothyroxine sodium 0.1 MG Oral Tablet
- RxCUI: 892251 - levothyroxine sodium 200 MCG Oral Tablet
- RxCUI: 892251 - levothyroxine sodium 0.2 MG Oral Tablet
- RxCUI: 892255 - levothyroxine sodium 300 MCG Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 60846 - Amneal Pharmaceuticals Llc
- 60846-803 - Unithroid
- 60846-803-01 - 100 TABLET in 1 BOTTLE
- 60846-803 - Unithroid
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 60846-803-01 identifies a specific commercial package of 100 tablet in 1 bottle of Unithroid, a human prescription drug labeled by Amneal Pharmaceuticals Llc. This tablet is formulated for oral use and contains levothyroxine sodium as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Amneal Pharmaceuticals Llc on July 03, 2014. The current certification is valid through December 31, 2027.
How is this Amneal Pharmaceuticals Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 60846080301. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 100 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.